Bill · H.R. 5435· House(119-HR-5435)
Stop CMV Act of 2025
- Introduced
- 9/17/2025
- Last activity
- 9/17/2025 — Referred to the House Committee on Energy and Commerce.
- Sponsored by
- Michael Lawler
- Cosponsors
- - 2 - 10
- Introduced
- In Committee
What this bill would do
The "Stop CMV Act of 2025" amends the Public Health Service Act to allow hospitals and health care entities to screen newborns aged 21 days or less for congenital Cytomegalovirus. State health officers can set standards for testing, recording results, and educating parents. If a state fails to set these standards within two years, an Advisory Committee will do so. The bill provides grants for administering tests and technical assistance for data collection and public education. Additionally, it directs the National Institutes of Health to research screening techniques, diagnostics, treatments, and vaccine development.
Yes· 3 of 11
Would children be better off under this?+10
Directly benefits infants through early detection and treatment of congenital CMV.
Does this put more money into medical research?+8
Directs NIH to expand research into diagnostics, treatments, and vaccine development for CMV.
Does this put more money into scientific research?+8
Provides for NIH research into new screening technology and medical cures for CMV.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Newborn Screening: Hospitals and health care entities caring for infants 21 days or younger can administer tests for congenital Cytomegalovirus, which helps in identifying the condition in newborns (Section 2(a)).
-
Public Education and Training: Grants through the CDC provide for the education and training of health care providers, patients, and the general public regarding prevention, symptoms, diagnosis, and treatment of the virus (Section 2(c)(2)(A)(ii)).
-
Medical Advancement: The National Institutes of Health would establish or expand research into new screening technology, diagnostics, vaccines, and cures or treatments for both during pregnancy and after birth (Section 2(c)(3)(B)).
-
Financial Support for Testing: The Secretary will award grants to States to be distributed to health care entities to help administer the tests (Section 2(c)(1)(A)).
Potential Negative Impacts for People
- No negative impacts for individuals or groups of people are explicitly mentioned in the provided text.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Hover a score for the reason it gave.
- Demographic And Interest Groups
- Good For Children+10Good For Women+6Good For High Income Households+5Good For Low Income Households+5Good For Middle Class Households+5Good For People With Disabilities+5
- Healthcare
- Increases Research Funding+8Improves Healthcare Access+6
- Education And Technology
- Increases Scientific Research Funding+8
- Governance And Ideology
- Increase States Rights+3Increases Federal Power+2
- 10/1/2026
- 1 Cosponsor added.
- 3/26/2026
- 1 Cosponsor added.
- 3/17/2026
- 1 Cosponsor added.
- 1/7/2026
- 1 Cosponsor added.
- 12/15/2025
- 1 Cosponsor added.
- 11/19/2025
- 1 Cosponsor added.
- 11/17/2025
- 2 Cosponsors added.
- 10/17/2025
- 1 Cosponsor added.
- 10/8/2025
- 1 Cosponsor added.
- 9/17/2025
- Referred to the House Committee on Energy and Commerce.
- 2 Cosponsors added.
- Introduced in House
One bill Congress.gov lists as related to this one — companions in the other chamber, earlier versions, and bills this one absorbed or was folded into.
Mark AlfordRepublican · Missouri
Yassamin AnsariDemocrat · Arizona
Josh GottheimerDemocrat · New Jersey
Laura GillenDemocrat · New York
Jennifer KiggansRepublican · Virginia
Greg LandsmanDemocrat · Ohio
Eleanor NortonDemocrat · District of Columbia
Chris PappasDemocrat · New Hampshire
Deborah RossDemocrat · North Carolina
Kim SchrierDemocrat · Washington
Eric SorensenDemocrat · Illinois
Eugene VindmanDemocrat · Virginia